Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Acid-Based Decalcification Methods Compromise Genomic Profiling from DNA and RNA

Ian Duncan, Natalie Danziger, Daniel Duncan, MD, Amanda Hemmerich, MD, Claire Edgerly, MD, Richard Huang, MD, Jo-Anne Vergilio, MD, Julia A Elvin, MD PhD, Jie He, PhD, Nicholas Britt, Prasanth Reddy, MD, Pratheesh Sathyan, MD, Brian Alexander, MD, Jeffrey S. Ross, MD, Charlotte Brown, PhD, Shakti H. Ramkissoon, MD PhD, Eric A. Severson, MD, PhD, MMSc

Blood (2019) 134 (Supplement_1): 4659.

https://doi.org/10.1182/blood-2019-131362

Published: 2019

Journal Articles

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Lucas R. Massoth, MD, Yin P. Hung, MD, PhD, Judith A. Ferry, MD, Robert P. Hasserjian, MD, Abner Louissaint, Jr., MD PhD, Meagan Montesion, PhD, Ethan S. Sokol, PhD, Dean C. Pavlick, Nikunj Shah, Natalie Danziger, Jonathan Keith Killian, MD,PhD, Eric A. Severson, MD, PhD, MMSc, Daniel Duncan, MD, Julia A. Elvin, MD, PhD, Vincent A. Miller, MD, Jeffrey S. Ross, MD, Jo-Anne Vergilio, MD, Lawrence R. Zukerberg, MD, Erik A. Williams, MD

Blood (2019) 134 (Supplement_1): 2541.

https://doi.org/10.1182/blood-2019-123729

Published: 2019

Journal Articles

Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency

Eric A. Severson, MD, PhD, MMSc, Ethan S. Sokol, PhD, Russell Madison, PhD, Daniel Duncan, MD, Amanda Hemmerich, MD, Claire Edgerly, MD, Richard Huang, MD, Nicholas Britt, Jo-Anne Vergilio, MD, Julia A Elvin, MD PhD, Prasanth Reddy, MD, Pratheesh Sathyan, MD, Brian Alexander, MD, Jeffrey S. Ross, MD, Siraj M Ali, MD PhD, Shakti H. Ramkissoon, MD PhD

Blood (2019) 134 (Supplement_1): 1437.

https://doi.org/10.1182/blood-2019-131248

Published: 2019

Journal Articles

Recurrent Copy Number Variants Are Highly Prevalent in Acute Myeloid Leukemia

Katherine Tarlock, MD, Yuting He, James Sun, Rhonda E. Ries, MA, Eric A Severson, MD PhD MMSc, Mark Bailey, MS, Samantha Morley, PhD, Sohail Balasubramanian, Rachel Erlich, PhD, Doron Lipson, PhD, Geoff Otto, PhD, Jo-Anne Vergillo, Jeffrey S Ross, MD, Tariq Mughal, FRCP, Phil Stephens, PhD, Vincent Miller, MD, Soheil Meshinchi, MD PhD, Jie He, PhD

Blood (2017) 130 (Supplement 1): 3800.

https://doi.org/10.1182/blood.V130.Suppl_1.3800.3800

Published: 2017

Journal Articles

Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors

Eric A Severson, MD PhD MMSc, Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Vincent A Miller, MD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Shakti Ramkissoon, MD PhD

Blood (2017) 130 (Supplement 1): 3996.

https://doi.org/10.1182/blood.V130.Suppl_1.3996.3996

Published: 2017

Journal Articles

Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Eric A Severson, MD PhD MMSc, Caitlin F Connelly, PhD, Shakti Ramkissoon, MD PhD, Garrett M Frampton, PhD, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Vincent A Miller, MD, Philip J Stephens, PhD, Siraj M Ali, MD PhD, Jeffrey S Ross, MD, Jo-Anne Vergilio, MD

Blood (2017) 130 (Supplement 1): 115.

https://doi.org/10.1182/blood.V130.Suppl_1.115.115

Published: 2017

Journal Articles

Comprehensive Genomic Profiling (CGP) Informs Molecular Diagnosis, Prognosis, and Therapeutic Decision-Making for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)

Samantha Morley, PhD, Jie He, PhD, Andrew M Intlekofer, MD PhD, Mark Bailey, MS, Michelle Nahas, PhD, Andreas Heilmann, PhD, Yakov Chudnovsky, PhD, David Fabrizio, PhD, Siraj M Ali, MD PhD, Doron Lipson, PhD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Vincent A Miller, MD, Eric A Severson, MD PhD MMSc, Jo-Anne Vergilio, MD, Omar Abdel-Wahab, MD, Rachel Erlich, PhD, Tariq I Mughal, MD FRCP

Blood (2017) 130 (Supplement 1): 5134.

https://doi.org/10.1182/blood.V130.Suppl_1.5134.5134

Published: 2017

Journal Articles

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Lei Zhong, PhD, Mark Rosenzweig, PhD, Yakov Chudnovsky, PhD, Jie He, PhD, Michelle Nahas, PhD, Siraj M Ali, MD PhD, Sugganth Daniel, MD, Shakti Ramkissoon, MD PhD, James Suh, MD, Julia A Elvin, MD PhD, Tariq I Mughal, MD FRCP, Philip J Stephens, PhD, Vincent A Miller, MD, Rachel Erlich, PhD, Jeffrey S Ross, MD, Eric A Severson, MD PhD MMSc, Samantha Morley, PhD

Blood (2017) 130 (Supplement 1): 417.

https://doi.org/10.1182/blood.V130.Suppl_1.417.417

Published: 2017

Journal Articles

Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia

Eric A Severson, MD PhD MMSc, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Michelle Nahas, PhD, Vincent A Miller, MD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Shakti Ramkissoon, MD PhD, Jo-Anne Vergilio, MD

Blood (2017) 130 (Supplement 1): 476.

https://doi.org/10.1182/blood.V130.Suppl_1.476.476

Published: 2017

Journal Articles

Real-Time Genomic Profiling Identifies Novel Mutations and Improved Therapy for Histiocytoses

Lynn Lee, MD, Anjelika Gasilina, Jayeeta Roychoudhury, PhD, Jason Clark, Francis X McCormack, MD, Joseph Gerald Pressey, MD, Robert B. Lorsbach, MD PhD, Siraj M Ali, MD PhD, Mark Bailey, MSc, Philip Stevens, PhD, Jeffrey S Ross, MD, Vincent A. Miller, MD, Nicolas Nassar, PhD, Ashish R Kumar, MBBS, PhD

Blood (2016) 128 (22): 2723.

https://doi.org/10.1182/blood.V128.22.2723.2723

Published: 2016

Journal Articles

Genomic Alterations of Histone Modification Genes Are Significantly Less Common in Non-Hodgkin Lymphomas of Adolescents and Young Adults Compared to Older Patients

Kai Wang, MDPhD, Deborah Morosini, MD, Roman Yelensky, PhD, Norma Palma, PhD, Adrienne Johnson, MS, Doron Lipson, PhD, Juliann Chmielecki, PhD, Siraj Ali, MDPhD, Jeffrey S Ross, MD, Philip J. Stephens, PhD, Vincent Miller, MD

Blood (2014) 124 (21): 1684.

https://doi.org/10.1182/blood.V124.21.1684.1684

Published: 2014

Journal Articles

Clinical Utility of Comprehensive Profiling of Genomic Alterations in Hematologic Malignancies

Blood (2014) 124 (21): 1072.

https://doi.org/10.1182/blood.V124.21.1072.1072

Published: 2014

Journal Articles

Identification Of Actionable Genomic Alterations In Hematologic Malignancies By a Clinical Next Generation Sequencing-Based Assay

Blood (2013) 122 (21): 230.

https://doi.org/10.1182/blood.V122.21.230.230

Published: 2013

Journal Articles

Expression of Phosphorylated mTOR (p-mTOR) Correlates with Advanced Stage in Diffuse Large B-Cell Lymphomas.

Raina A. Patel, MD, Imran Ahmad, MD, Christine E. Sheehan, BA, Jeffrey S. Ross, MD, George D. Wilner, MD, Alida Hayner-Buchan, MD, Tipu Nazeer, MD

Blood (2007) 110 (11): 1573.

https://doi.org/10.1182/blood.V110.11.1573.1573

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Acid-Based Decalcification Methods Compromise Genomic Profiling from DNA and RNA

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency

Recurrent Copy Number Variants Are Highly Prevalent in Acute Myeloid Leukemia

Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors

Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Comprehensive Genomic Profiling (CGP) Informs Molecular Diagnosis, Prognosis, and Therapeutic Decision-Making for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia

Real-Time Genomic Profiling Identifies Novel Mutations and Improved Therapy for Histiocytoses

Genomic Alterations of Histone Modification Genes Are Significantly Less Common in Non-Hodgkin Lymphomas of Adolescents and Young Adults Compared to Older Patients

Clinical Utility of Comprehensive Profiling of Genomic Alterations in Hematologic Malignancies

Identification Of Actionable Genomic Alterations In Hematologic Malignancies By a Clinical Next Generation Sequencing-Based Assay

Expression of Phosphorylated mTOR (p-mTOR) Correlates with Advanced Stage in Diffuse Large B-Cell Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only